IV vs. Oral Ketamine: A Comparative Analysis

Treatment-resistant depression (TRD) presents a significant challenge in mental health care, with traditional antidepressants often falling short in providing relief. In recent years, ketamine has emerged as a promising alternative for individuals who do not respond to conventional treatments. However, the administration of ketamine can vary, with intravenous (IV) and oral routes being two primary options.

In this article, we will explore the differences between IV and oral ketamine, examining their pharmacology, benefit/effectiveness, and potential side effects.

Pharmacology

Ketamine is a dissociative anesthetic that exerts its antidepressant effects by influencing the glutamatergic system. Both IV and oral ketamine have distinct pharmacokinetic profiles, which can impact their effectiveness and side effect profiles.

IV Ketamine

  • Route of Administration: Intravenous injection.

  • Pharmacokinetics: Rapid onset of action, with peak plasma levels occurring within minutes.

  • Metabolism: Rapid metabolism to inactive metabolites, primarily in the liver.

  • Onset of Action: 2-5 minutes.

  • Duration of Action: Short-lived, typically lasting around 1 hour.

  • Bioavailability: 100%.

Oral Ketamine

  • Route of Administration: Oral troche or disintegrating tablet.

  • Pharmacokinetics: Slower onset, with peak plasma levels reached within 1-2 hours.

  • Metabolism: Hepatic metabolism, similar to IV ketamine.

  • Onset of Action: 10-20 minutes.

  • Duration of Action: Prolonged, with effects lasting up to 2-4 hours or more.

  • Bioavailability: Variable, typically around 35%.

Benefit/Effectiveness

Both IV and oral ketamine have demonstrated efficacy in treating TRD, but the choice between the two depends on individual patient needs and clinical circumstances.

IV Ketamine

  • Rapid Relief: IV ketamine often provides a faster response, which can be especially beneficial in crisis situations. Possibility of same day signup and infusion.

  • Clinician Supervision: Administration is performed in a medical setting, allowing for close monitoring and adjustment of dosage if needed.

  • Safety: Close monitoring of vital signs and supervision by trained physicians to handle any emergent side effects.

Oral Ketamine

  • Convenience: Oral ketamine can be taken at home, reducing the need for frequent clinic visits.

  • Extended Duration: Longer-lasting effects can result in more sustained relief, potentially reducing the frequency of dosing.

  • Patient Autonomy: Patients can have more control over their treatment, taking the medication as prescribed.

  • Cost Effective: Typically less expensive than the IV option.

Side Effects

The side effect profile of IV and oral ketamine shares many similarities due to their common pharmacology, but there are some differences worth noting.

Common Side Effects for Both Routes

  • Dissociation

  • Nausea and vomiting

  • Increased blood pressure and heart rate

  • Sedation

IV Ketamine

  • Potential for more pronounced dissociation during administration.

  • Requires medical supervision to manage potential side effects.

Oral Ketamine

  • Generally, milder dissociation.

  • Some patients may experience gastrointestinal issues due to the oral route.

Table: A Comparative Summary of IV and Oral Ketamine

Nasal Ketamine

In addition to intravenous and oral administration, there is also a nasal spray option for ketamine called Spravato. Spravato, which contains esketamine, has gained recognition as a valuable treatment for individuals with treatment-resistant depression (TRD). One of the key benefits of this nasal spray is its relative ease of use and convenience, making it a more accessible option for some patients compared to IV ketamine. It may also be preferred in patients who have difficulty taking the oral option.

Conclusion

IV and oral ketamine are both viable options for the treatment of treatment-resistant depression. The choice between the two depends on various factors, including the patient's clinical status, convenience, and the level of clinician supervision required. Understanding the differences in pharmacology, benefit/effectiveness, and side effects can help clinicians and patients make informed decisions to find the most suitable treatment approach for TRD.


Discreet Ketamine provides ketamine therapy for at-home treatment to Florida residents.


Dr. Ben Soffer

Former chair of Internal Medicine at St. Mary’s Medical Center in West Palm Beach, Florida and associate professor at FAU Medical School. Dr. Ben is the owner of a concierge Internal Medicine practice in Palm Beach County, Florida and Discreet Ketamine, a telemedicine mental health practice servicing the entire state. He resides in Boca Raton, Florida with his wife and four children.

Previous
Previous

ODT/RDT vs. Troche: Maximizing Oral Drug Absorption

Next
Next

Ketamine History: Its Origin and Science